We verify Carelon Behavioral Health benefits at no cost for clients across Fresno, Los Angeles, and statewide California — file prior authorization with Carelon directly, and advocate through peer-to-peer review and appeals when the level of care your clinical assessment supports is challenged. Coverage typically includes medical detox, residential treatment, MAT, partial hospitalization, intensive outpatient, and aftercare.
In most cases, yes. Carelon Behavioral Health is the behavioral-health benefit administrator for many Anthem and Elevance commercial plans, and most Carelon-managed plans cover medical detox, residential treatment, medication-assisted treatment, partial hospitalization, intensive outpatient, and structured aftercare. Coverage depends on your specific employer plan and any prior-authorization requirements your group has set. Our utilization-review team verifies your Carelon benefits at no cost and sends a written breakdown — covered levels of care, expected length-of-stay authorization, and any cost-sharing — typically within 30 minutes.
If your medical card says Anthem on the front, but the behavioral-health or mental-health section names Carelon (or Beacon Health Options, the prior brand name), this is the verification path that applies to you.
Most Carelon-managed plans cover the levels of care across the substance-use treatment continuum. The specifics depend on your plan, but the typical authorization windows we see are:
Specific authorization length depends on your plan, the clinical assessment at intake, and concurrent-review decisions Carelon makes during your stay. Our team documents medical necessity at every checkpoint.
Carelon plans cover a defined level of care. The quality of that care depends on where you go.
These are the components that determine whether a Carelon authorization translates into recovery or into days of treatment. We are built for the former.
This is where the work happens. Insurance coverage of substance-use treatment isn’t a one-time approval — it’s a series of clinical-necessity reviews that begin before admission and continue through every level of care. Carelon-managed cases require active authorization tracking; some plans build in tighter review windows than others. Our utilization-review and billing team handles the full cycle.
The decision to escalate is not commercial. It’s clinical. When a client is denied care that’s clinically indicated, we advocate for them — through every step above — to support coverage of the level of care our team believes is medically appropriate.
Two pieces of law shape what Carelon — or any commercial behavioral-health administrator — is required to cover.
When we appeal a Carelon denial, the appeal is built on the clinical documentation and the law. Both sides matter.
The 28-day inpatient stay became the industry default in the 1980s based on insurance design, not clinical evidence. The clinical evidence points the other direction. The National Institute on Drug Abuse, summarizing decades of research in its Principles of Effective Treatment, states that participation in treatment for less than 90 days is of limited effectiveness for most substance-use disorders, and that better outcomes are associated with longer durations of treatment. This includes time across the full continuum — detox, residential, PHP, IOP, and continuing care.
This is why we build for length-of-stay flexibility. Some clients need a focused inpatient stay because of work or family constraints, then continue at PHP or IOP. Others — those with severe withdrawal risk, complex psychiatric comorbidity, or chronic relapse history — need extended residential care. The right length of stay is a clinical decision, not a calendar decision.
When concurrent review tries to cut a stay short, our UR and medical teams document the clinical reasoning, file the peer-to-peer request, and pursue appeals when warranted.
Some of the groups whose plans use Carelon for behavioral-health management:
If your card lists Carelon, Beacon, or simply names a behavioral-health phone number that routes to either, our UR team can walk through the verification with you.
Three steps. No commitment.
Most Carelon plans cover medical detox when it’s medically indicated. Authorization windows we typically see are 3 to 15 days, depending on the substance, withdrawal severity, and medical or psychiatric complexity. Coverage depends on your specific plan and prior-authorization requirements. Our UR team verifies the specifics with Carelon directly before admission.
In most cases, yes. Carelon-managed plans typically cover residential treatment (ASAM Level 3.5) when medical-necessity criteria are met. Initial authorizations we see are usually 20 to 45 days, with concurrent reviews evaluating continued stay. California’s SB 855 requires state-regulated commercial plans to cover medically necessary treatment for substance-use disorders — and to use nationally recognized criteria like ASAM in deciding what’s medically necessary.
Most Carelon plans require prior authorization for medical detox and residential admission. Our UR team files the prior-auth request with the clinical documentation supporting medical necessity, typically before admission. You don’t handle the prior-auth process yourself.
When Carelon denies a request that our clinical and medical team believes is clinically indicated, our medical director conducts a peer-to-peer review with Carelon’s medical director. If the denial holds after peer-to-peer, we file Level-1 and Level-2 internal appeals with the supporting clinical documentation. When internal appeals are exhausted and the denial is not clinically defensible, we handle external appeals — California Independent Medical Review for state-regulated plans, or ERISA-track external review for self-funded employer plans.
Most Carelon plans cover MAT for opioid use disorder (buprenorphine, naltrexone) and for alcohol use disorder (naltrexone, acamprosate) when prescribed as part of a clinical treatment plan. Coverage of specific medications depends on your plan’s formulary and any prior-authorization requirements. Our medical director prescribes MAT when it’s clinically indicated.
Yes. Beacon Health Options was acquired by Anthem in 2020 and rebranded to Carelon Behavioral Health in 2023. If your card or your plan documents reference Beacon, the coverage and the verification path are the same as Carelon. Our UR team handles either one.
Most Carelon plans cover treatment of co-occurring psychiatric conditions alongside substance-use treatment when both are clinically indicated. The federal Mental Health Parity and Addiction Equity Act requires plans that cover MH and SUD benefits to apply financial and treatment limitations no more stringently than they apply to medical and surgical benefits. We treat the depression that drove the drinking, the trauma underneath the opioid use, the bipolar diagnosis someone has been self-medicating — alongside the substance-use work, not after it.
Our UR team can have a written breakdown of your Carelon coverage back to you within 30 minutes — covered levels of care, prior-authorization requirements, and any cost-sharing. Verification is free, confidential, and not a commitment to admit.
Carelon Behavioral Health and Beacon Health Options are trademarks of their respective owners. References to Carelon are made for informational purposes only. Insurance acceptance is subject to benefit verification. Treatment outcomes vary by individual; statements about the authorization, peer-to-peer, and appeals process describe Gev’s Recovery’s standard practices and do not guarantee specific coverage decisions by your plan. Gev’s Recovery Center · 19448 Lassen St, Northridge, CA 91324 · CA DHCS license #191288AP.
